Drug profile · INN
brodalumab
KYNTHEUM
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
brodalumab (KYNTHEUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN brodalumab
Brand KYNTHEUM
Route INJECTION
Formulation INJECTABLE
ATC code L04AC12
Frequently asked questions
What is brodalumab?
brodalumab (KYNTHEUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for brodalumab?
KYNTHEUM is a marketed brand name for brodalumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of brodalumab?
brodalumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.